Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Allele Traits

Multiple Allele Traits

The Concept of Multiple Allelism

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...

Genetic Lingo

Genetic Lingo

Blood Types

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

UGT1A1 polymorphisms and gallbladder-related outcomes in sickle cell disease in Brazil.

Annals of hematology·2026

Same author

Lactate dehydrogenase (LDH) as a predictor of left atrial remodeling in patients with sickle cell anemia.

Annals of hematology·2026

Same author

Immature platelets: A useful tool for thrombocytopenia etiology classification in adults.

Hematology, transfusion and cell therapy·2026

Same author

Criteria for referring pediatric and adult patients with hematological diseases to palliative care: Consensus of the Brazilian Association of Hematology, hemotherapy and cell therapy (2025).

Hematology, transfusion and cell therapy·2026

Same author

Drug development for sickle cell disease: repeated setbacks, yet there remains an optimistic outlook for future breakthroughs.

Hematology, transfusion and cell therapy·2026

Same author

Sustained expression of hemopexin in an animal model of sickle cell anemia.

Blood vessels, thrombosis & hemostasis·2026

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Haptoglobin genotypes in sickle-cell disease.

Magnun Nueldo Nunes Santos¹, Marcos André Cavalcanti Bezerra, Betânia Lucena Tavares Borges Domingues

¹Department of Clinical Pathology, School of Medical Sciences, State University of Campinas-UNICAMP, Campinas, São Paulo, Brazil.

Genetic Testing and Molecular Biomarkers

|June 10, 2011

Summary

Haptoglobin (Hp) genotype frequencies in sickle-cell disease patients showed no significant differences compared to controls. However, Hp2-2 was less common in patients than Hp1-1, suggesting a potential role in disease diversity.

More Related Videos

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

Related Experiment Videos

Last Updated: Jun 1, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

Area of Science:

Genetics
Hematology
Population Studies

Background:

Sickle-cell disease (SCD) is a genetic blood disorder with significant clinical variability.
Haptoglobin (Hp) is a protein involved in hemoglobin binding, with known genetic polymorphisms (Hp1-1, Hp1-2, Hp2-2).
The role of Hp genotypes in the pathophysiology or clinical course of SCD remains incompletely understood.

Purpose of the Study:

To investigate the frequencies of haptoglobin (Hp) genotypes in a cohort of Brazilian sickle-cell disease patients across different age groups.
To compare Hp genotype distributions between SCD patients and a healthy control group.
To explore potential associations between Hp genotypes and age-related patterns in SCD.

Main Methods:

Genotyping of haptoglobin (Hp) in 775 Brazilian patients with sickle-cell disease.
Stratification of patients into age groups: 3 months-5 years, 6-10 years, 11-15 years, 16-20 years, and over 20 years.
Comparison of Hp genotype frequencies between patient age groups, and between older patients (>20 years) and healthy controls, including specific age subgroups (21-30 years and >30 years).

Main Results:

No significant differences in Hp genotype frequencies were observed between different patient age groups or between patients and controls overall.
The Hp2-2 genotype was consistently less frequent than the Hp1-1 genotype in patient groups.
In contrast, the Hp1-1 genotype was less frequent than Hp2-2 in healthy controls. Hp2-2 frequency decreased with age in patients (>20 years).

Conclusions:

Haptoglobin genotype frequencies do not significantly differ between sickle-cell disease patients and healthy controls in this Brazilian population.
While Hp2-2 is less frequent in SCD patients compared to controls, this polymorphism alone may not confer a significant selective advantage or disadvantage.
Hp genotypes might interact with other genetic and environmental factors, potentially contributing to the observed clinical diversity in sickle-cell disease.